Fundraising Fox

Edgewise Therapeutics

Boulder, US · Founded 2017 · 144 employees on LinkedIn · 3 known investors

Edgewise Therapeutics develops precision therapeutics for serious cardiovascular disease.

BiotechDigital Health

Investors · 3

Boulder VenturesBoulder · $1M – $4M
OrbiMedNew York · $1M – $75M
US Venture PartnersMenlo Park · $500K – $10M

Founder mafia

2 people who came through Edgewise Therapeutics went on to found or lead other companies.

Peter ThompsonChairman, Co-FounderFounded Cleave Biosciences +3Peter Thompson, M.D.Chairman, Co-FounderFounded Cleave Biosciences +3

In the news

44,466 Shares in Edgewise Therapeutics, Inc. $EWTX Bought by GSA Capital Partners LLP - Markets Dailythemarketsdaily.com · Aug 2026Edgewise Therapeutics CBO sells $223k in shares for tax obligations By Investing.comin.investing.com · Aug 2026Edgewise Therapeutics CMO Joanne Donovan sells $412,703 in stock By Investing.cominvesting.com · Aug 2026RBC Capital raises Edgewise Therapeutics price target on trial data By Investing.cominvesting.com · Jun 2026Edgewise Therapeutics Raises $50M in Series B Financing - FinSMEsfinsmes.com · Sep 2019

Frequently asked questions

What does Edgewise Therapeutics do?
Edgewise Therapeutics develops precision therapeutics for serious cardiovascular disease.
Who are Edgewise Therapeutics's investors?
Edgewise Therapeutics's investors include Boulder Ventures, OrbiMed, US Venture Partners.
Where is Edgewise Therapeutics headquartered?
Edgewise Therapeutics is headquartered in Boulder, US.